Echinocandins – structure, mechanism of action and use in antifungal therapy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Echinocandins – structure, mechanism of action and use in antifungal therapy
Authors
Keywords
-
Journal
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
Volume 37, Issue 1, Pages 876-894
Publisher
Informa UK Limited
Online
2022-03-17
DOI
10.1080/14756366.2022.2050224
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Regulatory Review Approach for Evaluation of Micafungin for Treatment of Neonatal Candidiasis
- (2021) Gillian Taormina et al. CLINICAL INFECTIOUS DISEASES
- In Vitro Characterization of Twenty-One Antifungal Combinations against Echinocandin-Resistant and -Susceptible Candida glabrata
- (2021) Hazim O. Khalifa et al. Journal of Fungi
- Micafungin Inhibits Dengue Virus Infection through the Disruption of Virus Binding, Entry, and Stability
- (2021) Yen-Chen Chen et al. Pharmaceuticals
- In vitro and in vivo interaction of caspofungin with isavuconazole against Candida auris planktonic cells and biofilms
- (2021) Fruzsina Nagy et al. MEDICAL MYCOLOGY
- Biological Properties and Analytical Methods for Micafungin: A Critical Review
- (2020) Gabriel Davi Marena et al. CRITICAL REVIEWS IN ANALYTICAL CHEMISTRY
- Colistin interacts synergistically with echinocandins against Candida auris
- (2020) A.L. Bidaud et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Mutagenesis of echinocandin B overproducing Aspergillus nidulans capable of using starch as main carbon source
- (2020) Zhong-Ce Hu et al. PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY
- The Fungal Cell Wall: Candida, Cryptococcus, and Aspergillus Species
- (2020) Rocio Garcia-Rubio et al. Frontiers in Microbiology
- Population Analysis of Anidulafungin in Infants to Older Adults With Confirmed or Suspected Invasive Candidiasis
- (2020) Rujia Xie et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Anidulafungin liposome nanoparticles exhibit antifungal activity against planktonic and biofilm Candida albicans
- (2020) Noel Vera‐González et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
- Antifungal Drugs
- (2020) Jiří Houšť et al. Metabolites
- Unexpected cell wall alteration-mediated bactericidal activity of the antifungal caspofungin against vancomycin-resistant Enterococcus faecium
- (2020) Christophe Isnard et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Caspofungin: a review of its characteristics, activity, and use in intensive care units
- (2020) Seyed MohammadReza Hashemian et al. Expert Review of Anti-Infective Therapy
- In vitro interaction of isavuconazole and anidulafungin against azole-susceptible and azole-resistant Aspergillus fumigatus isolates
- (2020) J B Buil et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Recent Progress in the Discovery of Antifungal Agents Targeting the Cell Wall
- (2020) Wei Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Current Antimycotics, New Prospects, and Future Approaches to Antifungal Therapy
- (2020) Gina Wall et al. Antibiotics-Basel
- Review on Current Status of Echinocandins Use
- (2020) Martyna Mroczyńska et al. Antibiotics-Basel
- Pharmacokinetic and Pharmacodynamic Comparison of Intravenous and Inhaled Caspofungin
- (2020) Iching G. Yu et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Attributable mortality of candidemia after introduction of echinocandins
- (2020) Florian B. Cornely et al. MYCOSES
- Elevated Vacuolar Uptake of Fluorescently Labeled Antifungal Drug Caspofungin Predicts Echinocandin Resistance in Pathogenic Yeast
- (2020) Qais Z. Jaber et al. ACS Central Science
- Echinocandins as Biotechnological Tools for Treating Candida auris Infections
- (2020) Elizabete de Souza Cândido et al. Journal of Fungi
- Review of the Novel Echinocandin Antifungal Rezafungin: Animal Studies and Clinical Data
- (2020) Yanan Zhao et al. Journal of Fungi
- Efficacy of Rezafungin in Prophylactic Mouse Models of Invasive Candidiasis, Aspergillosis, and Pneumocystis Pneumonia
- (2020) Lynn Miesel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Echinocandins: structural diversity, biosynthesis, and development of antimycotics
- (2020) Wolfgang Hüttel APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Global Epidemiology of Tuberculosis and Progress Toward Achieving Global Targets — 2017
- (2019) Adam MacNeil et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Pharmacokinetics of Caspofungin in Critically Ill Patients in Relation to Liver Dysfunction: Differential Impact of Plasma Albumin and Bilirubin Levels
- (2019) S. Kurland et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Echinocandins for the treatment of invasive aspergillosis: from laboratory to bedside
- (2019) Marion Aruanno et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Resistance of Candida to azoles and echinocandins worldwide
- (2019) K.E. Pristov et al. CLINICAL MICROBIOLOGY AND INFECTION
- Development and multicentre validation of an agar-based screening method for echinocandin susceptibility testing of Aspergillus species
- (2019) Joseph Meletiadis et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Farnesol increases the activity of echinocandins against Candida auris biofilms
- (2019) Fruzsina Nagy et al. MEDICAL MYCOLOGY
- Evaluation of anidulafungin in the treatment of intra-abdominal candidiasis: a pooled analysis of patient-level data from 5 prospective studies
- (2019) Gabriele Sganga et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Factors influencing caspofungin plasma concentrations in kidney transplant patients with high incidence of invasive fungal infections
- (2019) Qianting Yang et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Synergistic effect of nikkomycin Z with caspofungin and micafungin against Candida albicans and Candida parapsilosis biofilms
- (2019) R. Kovács et al. LETTERS IN APPLIED MICROBIOLOGY
- Anidulafungin as an alternative treatment for Pneumocystis jirovecii pneumonia in patients who cannot tolerate trimethoprim/sulfamethoxazole
- (2019) Po-Yi Chen et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Azole antifungals and new targeted therapies for hematological malignancy
- (2019) Julian Lindsay et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Micafungin Enhances the Human Macrophage Response to Candida albicans through β-Glucan Exposure
- (2018) José Pedro Guirao-Abad et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- FKS2 and FKS3 Genes of Opportunistic Human Pathogen Candida albicans Influence Echinocandin Susceptibility
- (2018) Sumanun Suwunnakorn et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicentre determination of rezafungin (CD101) susceptibility of Candida species by the EUCAST method
- (2018) M.C. Arendrup et al. CLINICAL MICROBIOLOGY AND INFECTION
- Echinocandins: Their role in the management of Candida biofilms
- (2018) Shweta Kamat et al. Indian Journal of Medical Microbiology
- Rezafungin (CD101) demonstrates potent in vitro activity against Aspergillus, including azole-resistant Aspergillus fumigatus isolates and cryptic species
- (2018) Nathan P Wiederhold et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Micafungin versus posaconazole prophylaxis in acute leukemia or myelodysplastic syndrome: A randomized study
- (2018) David J. Epstein et al. JOURNAL OF INFECTION
- Invasive Fungal Infections in Patients with Hematological Malignancies: Emergence of Resistant Pathogens and New Antifungal Therapies
- (2018) Maria N. Gamaletsou et al. Turkish Journal of Hematology
- Rezafungin (CD101), a next-generation echinocandin: A systematic literature review and assessment of possible place in therapy
- (2018) Amelia K. Sofjan et al. Journal of Global Antimicrobial Resistance
- Invasive Candidiasis in the Elderly: Considerations for Drug Therapy
- (2018) B. G. J. Dekkers et al. DRUGS & AGING
- Micafungin is a novel anti-viral agent of chikungunya virus through multiple mechanisms
- (2018) Yi-Jung Ho et al. ANTIVIRAL RESEARCH
- Molecular bases of antifungal resistance in filamentous fungi
- (2017) Cheshta Sharma et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Efficacy of anidulafungin in 539 patients with invasive candidiasis: a patient-level pooled analysis of six clinical trials
- (2017) Bart Jan Kullberg et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Echinocandins in antifungal pharmacotherapy
- (2017) Akash Patil et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Pharmacokinetics of caspofungin acetate to guide optimal dosing in cats
- (2017) Jana Leshinsky et al. PLoS One
- Preclinical Evaluation of the Stability, Safety, and Efficacy of CD101, a Novel Echinocandin
- (2016) Voon Ong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety and Pharmacokinetics of CD101 IV, a Novel Echinocandin, in Healthy Adults
- (2016) Taylor Sandison et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- CD101: a novel long-acting echinocandin
- (2016) Yanan Zhao et al. CELLULAR MICROBIOLOGY
- CD101, a novel echinocandin with exceptional stability properties and enhanced aqueous solubility
- (2016) B Radha Krishnan et al. JOURNAL OF ANTIBIOTICS
- Antiviral activity of micafungin against enterovirus 71
- (2016) Chonsaeng Kim et al. Virology Journal
- Metal Chelation as a Powerful Strategy to Probe Cellular Circuitry Governing Fungal Drug Resistance and Morphogenesis
- (2016) Elizabeth J. Polvi et al. PLoS Genetics
- Altered Micafungin Pharmacokinetics in Intensive Care Unit Patients
- (2015) Vincent J. Lempers et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Echinocandins: The Expanding Antifungal Armamentarium
- (2015) Daniel Aguilar-Zapata et al. CLINICAL INFECTIOUS DISEASES
- Echinocandin Resistance in Candida
- (2015) David S. Perlin CLINICAL INFECTIOUS DISEASES
- Impact of special patient populations on the pharmacokinetics of echinocandins
- (2015) Eline W Muilwijk et al. Expert Review of Anti-Infective Therapy
- Engineering of Glarea lozoyensis for Exclusive Production of the Pneumocandin B0Precursor of the Antifungal Drug Caspofungin Acetate
- (2014) Li Chen et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Echinocandin resistance
- (2014) Maiken C. Arendrup et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Antifungal drugs during pregnancy: an updated review
- (2014) B. Pilmis et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Phylogeny of the Clinically Relevant Species of the Emerging Fungus Trichoderma and Their Antifungal Susceptibilities
- (2014) M. Sandoval-Denis et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Mechanisms of Antifungal Drug Resistance
- (2014) Leah E. Cowen et al. Cold Spring Harbor Perspectives in Medicine
- Multicenter Study of Anidulafungin and Micafungin MIC Distributions and Epidemiological Cutoff Values for Eight Candida Species and the CLSI M27-A3 Broth Microdilution Method
- (2013) M. A. Pfaller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of Anidulafungin in Critically Ill Patients with Candidemia/Invasive Candidiasis
- (2013) Ping Liu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Echinocandins: production and applications
- (2013) Tamás Emri et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Synthesis and antifungal evaluation of pentyloxyl-diphenylisoxazoloyl pneumocandins and echinocandins
- (2013) Sheo B. Singh et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- In vitro antifungal susceptibility and molecular identity of 99 clinical isolates of the opportunistic fungal genus Curvularia
- (2013) Keith C. da Cunha et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- The Eagle-like effect of echinocandins: what’s in a name?
- (2013) Kim Vanstraelen et al. Expert Review of Anti-Infective Therapy
- Echinocandins in the treatment of candidaemia and invasive candidiasis: clinical and economic perspectives
- (2013) Chin Fen Neoh et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Discovery and development of first in class antifungal caspofungin (CANCIDAS®)—A case study
- (2013) James M. Balkovec et al. NATURAL PRODUCT REPORTS
- Facultative Sterol Uptake in an Ergosterol-Deficient Clinical Isolate of Candida glabrata Harboring a Missense Mutation inERG11and Exhibiting Cross-Resistance to Azoles and Amphotericin B
- (2012) Claire M. Hull et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Micafungin
- (2012) Lesley J. Scott DRUGS
- Total synthesis and structure–activity relationships of new echinocandin-like antifungal cyclolipohexapeptides
- (2012) Jianzhong Yao et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Evaluation of fungal-specific fluorescent labeled echinocandin probes as diagnostic adjuncts
- (2012) Ayiasha Pratt et al. MEDICAL MYCOLOGY
- Mutual influence of backbone proline substitution and lipophilic tail character on the biological activity of simplified analogues of caspofungin
- (2012) Monique P. C. Mulder et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Hidden Killers: Human Fungal Infections
- (2012) G. D. Brown et al. Science Translational Medicine
- Total synthesis and structure–activity relationships of caspofungin-like macrocyclic antifungal lipopeptides
- (2012) Jianzhong Yao et al. TETRAHEDRON
- In VitroEchinocandin Susceptibility ofAspergillusIsolates from Patients Enrolled in the Transplant-Associated Infection Surveillance Network
- (2011) Shawn R. Lockhart et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synthesis and evaluation of novel macrocyclic antifungal peptides
- (2011) Monique P.C. Mulder et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Current perspectives on echinocandin class drugs
- (2011) David S Perlin Future Microbiology
- Antifungal Susceptibility and Phylogeny of Opportunistic Members of the Order Mucorales
- (2011) Roxana G. Vitale et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Fitness and Virulence Costs of Candida albicans FKS1 Hot Spot Mutations Associated With Echinocandin Resistance
- (2011) Ronen Ben-Ami et al. JOURNAL OF INFECTIOUS DISEASES
- Echinocandins in Children
- (2011) Jill A. Hoffman et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Differential Aspergillus lentulus Echinocandin Susceptibilities Are Fksp Independent
- (2010) J. F. Staab et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Echinocandin Antifungal Drugs in Fungal Infections
- (2010) Sharon C.-A. Chen et al. DRUGS
- Spectrum of Clinically Relevant Acremonium Species in the United States
- (2010) H. Perdomo et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Evaluation of the Etest method for susceptibility testing ofAspergillusspp. andFusariumspp. to three echinocandins
- (2010) A. I. Martos et al. MEDICAL MYCOLOGY
- Echinocandins: The Newest Class of Antifungals
- (2009) Allana J Sucher et al. ANNALS OF PHARMACOTHERAPY
- Effect of Candida glabrata FKS1 and FKS2 Mutations on Echinocandin Sensitivity and Kinetics of 1,3- -D-Glucan Synthase: Implication for the Existing Susceptibility Breakpoint
- (2009) G. Garcia-Effron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The echinocandins: three useful choices or three too many?
- (2009) A.M. Bal INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Micafungin: a sulfated echinocandin
- (2009) Seiji Hashimoto JOURNAL OF ANTIBIOTICS
- Amphotericin B: side effects and toxicity
- (2009) Rafael Laniado-Laborín et al. REVISTA IBEROAMERICANA DE MICOLOGIA
- Micafungin
- (2009) Natalie J. Carter et al. PEDIATRIC DRUGS
- Novel echinocandin antifungals. Part 2: Optimization of the side chain of the natural product FR901379. Discovery of micafungin
- (2008) Masaki Tomishima et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Commercialization and Late-Stage Development of a Semisynthetic Antifungal API: Anidulafungin/d-Fructose (Eraxis)
- (2008) Timothy Norris et al. ORGANIC PROCESS RESEARCH & DEVELOPMENT
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now